BlackRock, Inc. 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 22,779,744 12.000% | 8,038,908 (+54.53%) | Filing |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 14,740,836 7.800% | -465,854 (-3.06%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 15,206,690 8.200% | 1,185,398 (+8.45%) | Filing |
| 2022-03-11 2:13 pm Unchanged | 2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 14,021,292 7.600% | 0 (Unchanged) | Filing |
| 2022-02-08 5:05 pm Sale | 2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 14,021,292 7.600% | -745,600 (-5.05%) | Filing |
| 2021-02-05 08:03 am Purchase | 2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 14,766,892 8.100% | 1,700,689 (+13.02%) | Filing |
| 2020-02-10 07:32 am Sale | 2019-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 13,066,203 7.300% | -521,984 (-3.84%) | Filing |